USPTO serial 79350388
NEMERA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 29, 2025
- Examiner
- FLETCHER, TRACY L
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with NEMERA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andy I. Corea
Andy I. Corea Harris Beach Murtha Cullina PLLC265 Church StreetNew Haven, CT 06510-1220United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Medical apparatus namely, drug delivery devices sold empty, in the nature of medical syringes, infusion sets, pump activated sprayers for dispensing medicine, atomizers for dispensing medicine, droppers for dispensing medicine, dosage dispensers for administering medicine to patients, medical fluid injectors, vaporizers for administering medicine, and inhalers; surgical instruments for medical use; protective equipment for surgical and medical apparatus and instruments, namely, protective cases fitted for surgical and medical instruments; cases specially adapted for the transport, storage and protection of devices for administering drugs, namely, cases specially adapted for drug delivery devices sold empty in the nature of syringes, infusion sets, pump activated sprayers for dispensing medicine, atomizers for dispensing medicine, droppers for dispensing medicine, dosage dispensers for administering medicine to patients, medical fluid injectors, vaporizers for administering medicine, and inhalers; apparatus for dosing and administering medical products for humans and animals, namely, inhalers for medical purposes sold empty, sprayers being atomizers sold empty for medical use, droppers for administering medication sold empty, dosage dispensers for administering medicine to patients, medical fluid injectors for administering medicine to patients, dermal distributers being applicators for delivering topical medications directly to skin in the nature of manually actuated push-button dispensers and injection devices being pen injectors, implant injectors and autoinjectors sold empty, and cases specially adapted therefor; dispensing apparatus for use in dispensing medical products for humans and animals, namely, aerosols dispensers being inhalers for medical purposes sold empty, vaporizers for medical use, droppers for administering medication sold empty, inhalers for medical purposes sold empty, and medical fluid injectors being pen injectors, implant injector and autoinjectors sold empty; security devices for use for protecting users of medical devices, namely, safety fitted covers and caps specially adapted for use with and sold as an integral component of drug delivery syringes and infusion sets sold empty, atomizers for medical use sold empty, droppers for administering medication sold empty, and dosage dispensers for administering medicine to patients; devices to be attached to containers for dispensing the contents of these containers, for medical use in humans or animals, namely, dosage dispensers for administering medicine to patients; closures for use in apparatus for dispensing, dosing and/or administering medical products used in humans or animals, namely, fitted covers specially adapted for dosage dispensers for administering medicine to humans and animal patients; pressurized dispensers for medical use being dosage dispensers for administering medicine to patients; packaging containers for the supply of medicines and pharmaceuticals being dispensers and applicators for administering medicine to patients, in the nature of pen injectors, implant injectors and autoinjectors sold empty, atomizers and vaporizers for medical use sold empty, droppers for administering medication sold empty, and dosage dispensers for administering medicine to patients; medicine injectors for administering medication sold empty, medical syringes sold empty, droppers for administering medication sold empty, injection pens sold without medication, infusion pumps for administering medicines, transdermal drug delivery patch sold without medication, portable injectors being medical fluid injectors for administering medication sold empty, patch pumps being medical infusion pumps, metering pumps being drug delivery pumps and vaporizers for medical use; apparatus for dosing and administering medical products for humans and animals, namely, inhalers sold empty, vaporizers, droppers sold empty, and injection devices being pen injectors, implant injectors and autoinjectors sold empty | ACTIVE | — |
| 021 | Dispensers made of plastic materials, namely, spray bottles for home use sold empty; dispensing pumps for attachment to aerosols and other containers of plastic, namely, manually actuated pump dispensers for attachment to containers for dispensing liquids, paste or powders for home use; plastic spray nozzles of plastic for use with pumps for dispensing liquid, powder or paste products; containers of plastic, for domestic use, for use in the storage of pharmaceutical and medical preparations, and plastic caps adapted therefor; empty spray bottles, bottles sold empty; all the aforesaid goods exclusively relating to packaging, packing and systems for dosing and dispensing, in the field of health, particularly for pharmaceutical, parapharmaceutical, medical and veterinary preparations | ACTIVE | — |
| 040 | Custom manufacture of apparatus for dosing, delivering or administering medical products for humans or animals, namely, inhalers, vaporizers, droppers and injection devices; custom manufacture of drug delivery devices and parts thereof for use in administering and dispensing medical products to humans or animals | ACTIVE | — |
| 042 | Technical research in the field of packaging, packages and pump systems used for dosing and dispensing medical, pharmaceutical and parapharmaceutical products; technical project planning and design of research studies, namely, conducting of feasibility studies in the field of packaging, packages and devices used for dosing or dispensing medical, pharmaceutical and parapharmaceutical products; industrial research services; quality control for third parties; pharmaceutical research services; industrial design services; graphic arts design services; design and development of electronic hardware and software related to medical and medicinal devices, instruments and tools, in particular add-ons or drug delivery devices, especially inhalers, sprayers, droppers and injection devices; research and development services for new products for third parties; technical consulting in relation to the aforesaid services; all the aforesaid services exclusively relating to packaging, analysis, plastics processing, and drug delivery systems, including medical apparatus, devices, instruments and tools, for drug dispensing and delivery especially injection molds and assembly machines for use in assembly, in the field of health, particularly for pharmaceutical, parapharmaceutical, medical and veterinary preparations | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Financière N
- Other trademarks owned by Financière N
- Other trademarks owned by Financière N
- Other trademarks in Class 010
- Other trademarks in Class 021
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named NEMERA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 18, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 11, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 14, 2025 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Nov 13, 2025 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Jul 29, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 29, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 29, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 11, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 11, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 5, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 14, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 13, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 13, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 13, 2025 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Oct 1, 2024 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| Oct 1, 2024 | GNSF | SUBSEQUENT FINAL EMAILED | — |
| Oct 1, 2024 | CFRC | SUBSEQUENT FINAL REFUSAL WRITTEN | — |
| Aug 28, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 28, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 28, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 2, 2024 | RFNP | REFUSAL PROCESSED BY IB | — |
| Mar 18, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Feb 29, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 29, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 29, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 28, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 28, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 23, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 23, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 23, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Oct 16, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 16, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 16, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 4, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 4, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 4, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 2, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 16, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Apr 11, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 11, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 22, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 21, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 16, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 27, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 23, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 22, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |